Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Ointments: SOP for Preventing Contamination at Each Stage – V 2.0

Posted on By

SOP for Preventing Contamination at Each Stage – V 2.0

Procedure for Preventing Contamination at Each Stage

Department Production/Quality Assurance (QA)/Quality Control (QC)
SOP No. SOP/Ointment/040
Supersedes V 1.0
Page No. Page X of Y
Issue Date [Insert Issue Date]
Effective Date [Insert Effective Date]
Review Date [Insert Review Date]

1. Purpose

The purpose of this Standard Operating Procedure (SOP) is to establish a systematic approach for preventing contamination at each stage of ointment manufacturing. Proper contamination control ensures product safety, maintains GMP compliance, and prevents cross-contamination.

2. Scope

This SOP applies to all personnel involved in the manufacturing, handling, storage, and transfer of materials within the ointment production facility.

3. Responsibilities

  • Production Supervisor: Ensures adherence to contamination control measures.
  • Machine Operator: Follows hygiene protocols and cleaning procedures.
  • Quality Assurance (QA) Personnel: Conducts environmental monitoring and compliance checks.
  • Engineering Technician: Maintains and sanitizes equipment as per the cleaning schedule.
See also  Ointments: SOP for Visual Inspection After Cleaning - V 2.0

4. Accountability

The Production and QA Managers are accountable for ensuring that contamination control is implemented as per GMP standards and properly documented.

5. Procedure

5.1 Contamination Control Measures

  • Implement a cleanroom policy with restricted access.
  • Ensure personnel follow gowning procedures before entering manufacturing areas.
  • Maintain proper air filtration and ventilation systems.

5.2 Preventing Contamination at Different Stages

5.2.1 Raw Material Handling

  • Ensure raw materials are received in contamination-free packaging.
  • Verify raw material quality before use.
  • Store materials in designated clean areas.

5.2.2 Mixing and Emulsification

  • Ensure all mixing vessels and equipment are cleaned before use.
  • Maintain closed systems to prevent airborne contamination.
  • Monitor environmental conditions (temperature, humidity, airflow).

5.2.3 Cooling and Storage

  • Use sealed containers to prevent microbial growth.
  • Regularly clean storage tanks and ensure no residue buildup.
  • Keep the manufacturing area free from dust and debris.
See also  Ointments: SOP for Monitoring Real-Time Process Parameters - V 2.0

5.2.4 Filling and Packaging

  • Maintain sterile conditions during filling operations.
  • Ensure operators wear gloves and masks during handling.
  • Inspect packaging for defects that may cause contamination.

5.3 Handling Contamination Incidents

  • If contamination is detected, immediately halt production.
  • Isolate the affected batch and conduct a root cause analysis.
  • Implement corrective and preventive actions (CAPA) and document in the Contamination Incident Log.

5.4 Documentation and Approval

  • Record all contamination control measures in the Contamination Prevention Log.
  • QA must review and approve contamination reports.
  • Maintain records for regulatory inspections.

6. Abbreviations

  • GMP – Good Manufacturing Practices
  • QA – Quality Assurance
  • QC – Quality Control
  • CAPA – Corrective and Preventive Action

7. Documents

  • Contamination Prevention Log (Annexure-1)
  • Contamination Incident Log (Annexure-2)

8. References

  • WHO GMP Guidelines for Pharmaceutical Manufacturing
  • 21 CFR Part 211 – Current Good Manufacturing Practices
  • ICH Q7 Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients
See also  Ointments: SOP for Ensuring Batch Uniformity in Ointments - V 2.0

9. SOP Version

Version 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Contamination Prevention Log

Date Batch Number Stage Preventive Measure Verified By
01/02/2025 SOP/Ointment/001 Mixing Air filtration verified QA Officer
02/02/2025 SOP/Ointment/002 Filling Operator gloves changed QA Officer

Annexure-2: Contamination Incident Log

Date Batch Number Stage Contamination Type Corrective Action Approved By
03/02/2025 SOP/Ointment/003 Mixing Microbial growth detected Equipment sterilized QA Head
04/02/2025 SOP/Ointment/004 Filling Particulate matter observed Batch rejected QA Head

12. Revision History:

Revision Date Revision No. Details of Revision Reason for Revision Approved By
01/01/2024 1.0 Initial Version New SOP QA Head
01/02/2025 2.0 Updated SOP Format Standardization of Document QA Head
Ointments V 2.0 Tags:Ointment application SOP, Ointment batch record SOP, Ointment compounding SOP, Ointment dispensing SOP, Ointment filling SOP, Ointment formulation SOP, Ointment manufacturing SOP, Ointment microbiological testing SOP, Ointment pH testing SOP, Ointment production SOP, Ointment quality control SOP, Ointment stability study SOP, Pharmaceutical ointment SOP, SOP for ointment homogenization, SOP for ointment labeling, SOP for ointment mixing, SOP for ointment packaging, SOP for ointment preparation, SOP for ointment raw material testing, SOP for ointment shelf-life determination, SOP for ointment stability testing, SOP for ointment sterilization, SOP for ointment storage, SOP for ointment testing, SOP for ointment viscosity testing

Post navigation

Previous Post: SOP for Compliance with Global Animal Testing Regulations
Next Post: SOP for Conducting Safety Awareness Campaigns in the Workplace

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version